ARCHIVES

Congress Okays NIH Reauthorization, Allows NCI $472 Mil. More

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

In Brief: Eyre ACS President, Freeman President Elects, Kathleen Horsch Chairman, Davis Heads ASTRO

November 20, 1987

NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive”

June 11, 2010

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

NCI’s Douglas Lowy and John Schiller Honored with National Medal

December 12, 2014

CPSC Relies On NCI Findings For New Policy

July 21, 1978